On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdaySep 28, 2011 3:13 pm

FITT Highway Products Inc. (FHWY) ‏is “One to Watch”

FITT Highway Products, Inc. is a brand management Company that lists on the OTC Bulletin Board. FITT has entered into an Operating Agreement with F.I.T.T. Energy Products Inc. to perform a majority of their operating services. This includes, among other things, selling, marketing, producing, and distributing the "F.I.T.T. Energy Shot With Resveratrol". F.I.T.T. Energy Products will pay the Company a royalty for each energy shot sold. FITT Highway Products has their corporate headquarters in Mission Viejo, California. The Company focuses on customers in their twenties, thirties, and forties, who have an interest in fitness and health, as well as gaining…

Continue Reading

WednesdaySep 28, 2011 3:01 pm

BEFUT International (BFTI) Posts Q4, FY2011 Increases

BEFUT International Co. Ltd., a developer, manufacturer and distributor of wire and cable products in China, today announced its financial results for the fiscal year ended June 30, 2011. The company’s positive fourth quarter and full-year 2011 were fueled by several variables, including increased demand for the company’s current product offerings, as well as several patent pending products. "We are pleased to report strong growth in revenue and net income for fiscal 2011. Our product strategy, marketing strategy and strong R&D have been key drivers to our success. We continue to grow our traditional cable business, but are particularly focused…

Continue Reading

WednesdaySep 28, 2011 2:58 pm

YM BioSciences, Inc. (YMI) Begins Phase II Trial for Its CYT387 Drug

YM BioSciences Inc. is a drug development company. It is currently advancing three clinical stage products: CYT387, a small molecule, dual inhibitor of the JAK1/JAK2 kinases; CYT997, a vascular disrupting agent; and nimotuzumab, an EGFR-targeting monoclonal antibody. The company today announced that it has enrolled the first of 60 patients in its Phase II trial of CYT387. The drug is to be administered twice daily for the treatment of myelofibrosis. The trial is intended to further evaluate the safety and tolerability of YM BioScienes’ JAK1/JAK2 inhibitor, as well as its efficacy in reducing spleen size, improving symptoms and reducing transfusion…

Continue Reading

WednesdaySep 28, 2011 2:44 pm

TiVUS, Inc. (TIVU) Lets You Take Home Preferences with You

When you’re at home, what kind of electronic entertainment and computer setup do you prefer? The capabilities and arrangement of your home systems says a lot about you, the way you work, how you watch television, the way you communicate with the world. But then what’s it like when you’re on the road? Do you find yourself trying to cobble together limited hotel resources in an effort to get your work done or keep the family happy? Do you find yourself thinking how much easier it is at home, where you perhaps like to work on the Internet through your…

Continue Reading

WednesdaySep 28, 2011 2:12 pm

BeaconEquity.com: Elite Pharmaceuticals (ELTP) Allergy Product Launch Triggers 30% Gains

Shares of Elite Pharmaceuticals Inc., a specialty pharmaceutical company, soared in yesterday's trading after the company, along with ECR Pharmaceuticals, announced the launch of Lodrane D®, an immediate release formulation of brompheniramine maleate and pseudophedrine HCI. The product will be manufactured by Elite, and promoted and distributed by ECR in the U.S. It will be available over-the-counter. Elite will be entitled to revenues for the manufacturing, packaging and laboratory study services of the product, as well as royalties on sales. With the U.S. allergy market currently estimated at $3.5 billion, the product has huge potential. Jerry Treppel, chairman and CEO…

Continue Reading

WednesdaySep 28, 2011 2:08 pm

BeaconEquity.com: Don’t Sell your Gold; Buy the Dips, says Jim Rogers

Commodities king Jim Rogers made the rounds with the media yesterday, speaking to, among others, the The Economic Times of India regarding his latest thoughts on the gold price. Now living in Singapore, the 68-year-old American citizen reckons the gold price may meander lower in coming weeks, but strongly suggests that weaker prices present an opportunity for investors who missed the boat on this roaring bull market to jump aboard to higher prices he sees in the future due to the protracted sovereign debt crisis in the Europe, then, in the United States. “ . . . gold has been…

Continue Reading

WednesdaySep 28, 2011 2:06 pm

BeaconEquity.com: Cheap Healthcare Stock Trending Higher

Cytori Therapeutics Inc., a developer, manufacturer and seller of medical products and devices to allow the practice of regenerative medicine, last week announced that it signed into a Celution® System agreement with Apollo Hospitals. Apollo is one of the largest private healthcare groups in Asia. Cytori will provide the technology initially at Apollo’s select cosmetic surgery centers in India. Dr. Prathap C. Reddy, founder and chairman of Apollo Hospitals, said that the alliance with Cytori has the potential to revolutionize the delivery of personalized cell therapy in India. Cytori is looking to build a successful commercial business in India through…

Continue Reading

WednesdaySep 28, 2011 10:56 am

ecoTECH Energy Group, Inc. (ECTH) Awarded Major Contract from HosMedEx S.A. of Ecuador

Located in Seattle, Washington, ecoTECH is a development-stage renewable energy company that produces renewable and sustainable “green” energy products. Today, ecoTECH took a major step towards prominence with the announcement they have been awarded a $36 million contract from HosMedEx S.A. (Hospital Medical Express) of Ecuador. HosMedEx is a global company that imports instruments and appliances used in the medical sector. The contract will provide HosMedEx six Gar-Crete systems for use in 6 regions across Ecuador. ecoTECH will receive $6 million USD for each delivered system and a $6 million initial deposit from HosMedEx. ecoTECH’s Gar-Crete system is designed to…

Continue Reading

WednesdaySep 28, 2011 10:33 am

All American Gold Corp. (AAGC) Provides Update on Goldfield West Project Drilling Operations

All American Gold Corp. today reported an update on the drilling operations at its Goldfield West Project in Nevada. Drilling, which commenced at the south target of the property, is progressing on schedule with two reverse circulation drill holes, each to an approximate depth of 800 feet, having been completed. According to today’s press release, an additional two holes are in progress and scheduled for completion by the first week of October. The holes at the south target are to further investigate a 2,600 foot long structure that had been identified through previous geophysical surveys. The samples collected from the…

Continue Reading

WednesdaySep 28, 2011 10:16 am

Magic Software Enterprises Ltd. (MGIC) Video Chart for Wednesday, September 28, 2011

MGIC is holding a solid support level at $4.00. There is positive divergence going on with the indicators and the pps, which indicates to technical traders that the stock is trying to find a bottom. Support, of course, must hold with resistance getting heavier at $5.00. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered